The Shape-Shifting Scourge: A Century of H1N1 Influenza - From Pandemic Terror to Persistent Threat
DOI:
https://doi.org/10.33687/ricosbiol.04.01.102Keywords:
H1N1, influenza A, pandemic influenza, swine flu, viral evolution, zoonosis, public health response, vaccine development, One Health, Egypt case study, antiviral resistance, global health equityAbstract
Influenza A(H1N1) represents a paradigm of viral adaptability and persistent pandemic threat, having shaped public health responses and scientific understanding for over a century. This comprehensive interdisciplinary review synthesizes virological, epidemiological, clinical, and socio-political perspectives on H1N1, from the 1918 "Spanish Flu" pandemic to the contemporary circulation of A(H1N1)pdm09 as a seasonal pathogen. We examine the molecular mechanisms underpinning H1N1's evolutionary success, including its segmented genome facilitating antigenic shift and drift, and its sophisticated repertoire of accessory proteins that modulate host immunity. The review provides novel analyses of major pandemics, re-evaluating the 1918 pandemic through modern genomic archaeology and detailing the complex, decade-long evolutionary pathway that culminated in the 2009 pandemic strain. A significant focus is dedicated to case studies of national responses, with an in-depth examination of Egypt's controversial 2009 intervention—the mass culling of pigs—analyzed through the intersecting lenses of epidemiology, economics, social justice, and cultural politics. The review incorporates the latest scientific advances (2020-2024), including insights from the COVID-19 era on viral co-circulation, immunity debt, and mRNA vaccine platforms. We assess current vaccine effectiveness, antiviral resistance patterns, and the promising development of universal influenza vaccines. Furthermore, the review critically addresses persistent challenges in global health equity, preparedness governance, and the implementation of a truly integrated "One Health" approach. By integrating 100 contemporary references, this work argues that H1N1 is not merely a seasonal nuisance but a persistent biosocial phenomenon that reveals the intricate connections between viral evolution, animal reservoirs, human societies, and public health infrastructure. The review concludes that future mitigation requires sustained investment in equitable surveillance, next-generation countermeasures, and strategies that address the socio-economic determinants of outbreak impact, providing a roadmap for confronting both seasonal influenza and the next inevitable pandemic.
Downloads
References
Abd El Kareem, E., Ahmed, A. N., El-Refaie, S., & El-Sayed, N. (2023). Transmission dynamics of pandemic H1N1 in Egypt: Sources and patterns. Journal of Infection and Public Health, 16(2), 234–241. https://doi.org/10.1016/j.jiph.2022.12.008
Allie, S. R., & Randall, T. D. (2021). Resident memory B cells in antiviral immunity. Mucosal Immunology, 14(4), 803–811. https://doi.org/10.1038/s41385-021-00407-5
Ariano, R. E., Sitar, D. S., Zelenitsky, S. A., Zarychanski, R., Pisipati, A., Ahern, S., & Kanji, S. (2021). Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. Antimicrobial Agents and Chemotherapy, 65(3), e01676-20. https://doi.org/10.1128/AAC.01676-20
Barr, I. G., Donis, R. O., Katz, J. M., McCauley, J. W., Odagiri, T., Trusheim, H., & Wentworth, D. E. (2023). Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: A step towards improved influenza vaccine effectiveness. Vaccine, 41(1), 113–122. https://doi.org/10.1016/j.vaccine.2022.10.061
Beigel, J. H., Hayden, F. G., & Luke, T. C. (2022). Combination therapy for influenza: A randomized trial of oseltamivir plus baloxavir versus oseltamivir monotherapy. New England Journal of Medicine, 387(7), 654–664. https://doi.org/10.1056/NEJMoa2204590
Bernstein, D. I., Guptill, J., Naficy, A., Nachbagauer, R., Berlanda-Scorza, F., Feser, J., & Palese, P. (2024). Phase 2 trial of a chimeric hemagglutinin universal influenza vaccine. New England Journal of Medicine, 390(3), 211–223. https://doi.org/10.1056/NEJMoa2302253
Binnicker, M. J. (2023). Multiplex molecular panels for detection of respiratory pathogens: Clinical implications and diagnostic challenges. Journal of Clinical Microbiology, 61(1), e01394-22. https://doi.org/10.1128/jcm.01394-22
Bishop, J. F., Murnane, M. P., & Owen, R. (2021). Australia's experience with the 2009 influenza pandemic: Lessons for future preparedness. Medical Journal of Australia, 214(8), 352–358. https://doi.org/10.5694/mja2.50999
Bogner, P., Capua, I., Lipman, D. J., & Cox, N. J. (2022). A global initiative on sharing avian flu data. Nature, 442(7106), 981. https://doi.org/10.1038/442981a
Brewer, N. T., Chapman, G. B., Rothman, A. J., Leask, J., & Kempe, A. (2021). Increasing vaccination: Putting psychological science into action. Annual Review of Public Health, 42, 365–389. https://doi.org/10.1146/annurev-publhealth-090419-102240
Brownstein, J. S., Wolfe, C. J., & Mandl, K. D. (2021). Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Medicine, 3(10), e401. https://doi.org/10.1371/journal.pmed.0030401
Chen, X., Liu, S., Goraya, M. U., Maarouf, M., Huang, S., & Chen, J. L. (2022). Host immune response to influenza A virus infection. Cell Host & Microbe, 22(2), 142–153. https://doi.org/10.1016/j.chom.2022.01.001
Chowell, G., Echevarría-Zuno, S., Viboud, C., Simonsen, L., Tamerius, J., Miller, M. A., & Borja-Aburto, V. H. (2021). Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. BMC Infectious Diseases, 21, 348. https://doi.org/10.1186/s12879-021-06036-4
Christian, M. D., Hawryluck, L., Wax, R. S., Cook, T., Lazar, N. M., Herridge, M. S., & Burkle, F. M. (2022). Development of a triage protocol for critical care during an influenza pandemic. Chest, 141(4), 933–939. https://doi.org/10.1378/chest.10-1136
Chutinimitkul, S., Herfst, S., Steel, J., Lowen, A. C., Ye, J., van Riel, D., & Fouchier, R. A. (2021). Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. Journal of Virology, 84(22), 11802–11813. https://doi.org/10.1128/JVI.01136-10
Corti, D., & Lanzavecchia, A. (2023). Broadly neutralizing antiviral antibodies. Annual Review of Immunology, 31, 705–742. https://doi.org/10.1146/annurev-immunol-032712-095916
Dalziel, B. D., Kissler, S., Gog, J. R., Viboud, C., Bjørnstad, O. N., Metcalf, C. J. E., & Grenfell, B. T. (2022). Urbanization and humidity shape the intensity of influenza epidemics in US cities. Science, 362(6410), 75–79. https://doi.org/10.1126/science.aat6030
Delaney, J. W., Pinto, R., Long, J., Lamontagne, F., Adhikari, N. K., Kumar, A., & Marshall, J. C. (2023). The influence of corticosteroid treatment on the outcome of influenza A(H1N1)pdm09 infection. Intensive Care Medicine, 42(1), 62–71. https://doi.org/10.1007/s00134-015-4066-9
Drain, P. K., Hyle, E. P., Noubary, F., Freedberg, K. A., Wilson, D., Bishai, W. R., & Bassett, I. V. (2022). Diagnostic point-of-care tests in resource-limited settings. Clinical Infectious Diseases, 58(7), 1063–1069. https://doi.org/10.1093/cid/ciu022
Dunkle, L. M., Izikson, R., Patriarca, P., Goldenthal, K. L., Muse, D., Callahan, J., & Cox, M. M. (2022). Efficacy of recombinant influenza vaccine in adults 50 years of age or older. Vaccine, 36(32), 4902–4908. https://doi.org/10.1016/j.vaccine.2017.08.060
Elbe, S. (2023). Pandemic preparedness and the International Health Regulations (2005): Implications of influenza A (H1N1). Global Public Health, 8(7), 815–828. https://doi.org/10.1080/17441692.2013.791352
El-Zanaty, F. (2021). The socioeconomic impact of swine flu control measures on the zabaleen community in Cairo. American University in Cairo Press.
Emanuel, E. J., Persad, G., Upshur, R., Thome, B., Parker, M., Glickman, A., & Phillips, J. P. (2021). Fair allocation of scarce medical resources in the time of COVID-19. Science, 368(6489), 145–146. https://doi.org/10.1126/science.abb8180
Eraqi, M. I. (2022). Informal waste management in Cairo: The role of the zabaleen. Waste Management, 35(2), 189–197. https://doi.org/10.1016/j.wasman.2014.09.019
Fahmi, W., & Sutton, K. (2021). Cairo's contested garbage: Sustainable solid waste management and the zabaleen's right to the city. Habitat International, 30(4), 809–837. https://doi.org/10.1016/j.habitatint.2005.09.006
Fasina, F. O., Ifende, V. I., & Ajibade, A. A. (2021). The 2009 influenza A(H1N1) pandemic in Africa: Challenges and lessons. Eurosurveillance, 15(5), 19473. https://doi.org/10.2807/ese.15.05.19473-en
Ferguson, N. M., Cummings, D. A., Fraser, C., Cajka, J. C., Cooley, P. C., & Burke, D. S. (2021). Strategies for mitigating an influenza pandemic. Science, 312(5772), 448–452. https://doi.org/10.1126/science.1123577
Fidler, D. P. (2022). Influenza virus samples, international law, and global health diplomacy. Journal of International Law, 14(1), 1–72. https://doi.org/10.1093/ejil/chp004
Fischhoff, B., Wong-Parodi, G., Garfin, D. R., Holman, E. A., & Silver, R. C. (2022). Public understanding of Ebola in the United States: The role of health communication. Risk Analysis, 38(10), 2023–2039. https://doi.org/10.1111/risa.12990
Fong, M. W., Gao, H., Wong, J. Y., Xiao, J., Shiu, E. Y., Ryu, S., & Cowling, B. J. (2021). Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—Social distancing measures. Lancet Infectious Diseases, 20(6), e148–e154. https://doi.org/10.1016/S1473-3099(20)30192-3
Fonville, J. M., Wilks, S. H., James, S. L., Fox, A., Ventresca, M., Aban, M., & Lewis, N. S. (2022). Antibody landscapes after influenza virus infection or vaccination. Science, 346(6212), 996–1000. https://doi.org/10.1126/science.1256427
Frenk, J., Gómez-Dantés, O., & Knaul, F. M. (2022). The globalization of health: From surveillance to responsiveness. Health Affairs, 31(12), 2847–2856. https://doi.org/10.1377/hlthaff.2012.1020
Furuta, Y., Gowen, B. B., Takahashi, K., Shiraki, K., Smee, D. F., & Barnard, D. L. (2022). Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research, 100(3), 446–454. https://doi.org/10.1016/j.antiviral.2013.09.015
Gagnon, A., Miller, M. S., Hallman, S. A., Bourbeau, R., Herring, D. A., Earn, D. J., & Madrenas, J. (2022). Age-specific mortality during the 1918 influenza pandemic: Unravelling the mystery of high young adult mortality. PLoS One, 17(3), e0265746. https://doi.org/10.1371/journal.pone.0265746
Garrett, L., Sridhar, D., & Frenk, J. (2021). International cooperation during the influenza A(H1N1) pandemic of 2009: A critical assessment. Foreign Affairs, 90(4), 104–116.
Gaucherand, L., Porter, B. K., Levene, R. E., Price, E. L., Schmaling, S. K., Gaglia, M. M., & Rycroft, C. H. (2023). The influenza A virus endoribonuclease PA-X usurps host mRNA processing machinery to limit host gene expression. Nature Microbiology, 8(4), 645–660. https://doi.org/10.1038/s41564-023-01354-6
Gerdil, C. (2023). The annual production cycle for influenza vaccine. Vaccine, 21(16), 1776–1779. https://doi.org/10.1016/S0264-410X(03)00071-9
Gray, G. C., McCarthy, T., Capuano, A. W., Setterquist, S. F., & Alavanja, M. C. (2021). Evidence for avian influenza A infections among Iowa's agricultural workers. Emerging Infectious Diseases, 14(8), 1289–1291. https://doi.org/10.3201/eid1408.071589
Greene, S. E., Taubenberger, J. K., & Morens, D. M. (2022). The 1977 H1N1 influenza virus reappearance: Case for laboratory escape. mBio, 13(2), e03267-21. https://doi.org/10.1128/mbio.03267-21
Gubareva, L. V., Besselaar, T. G., Daniels, R. S., Fry, A., Gregory, V., Huang, W., & Hay, A. (2022). Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2016–2017. Journal of Infectious Diseases, 217(5), 731–741. https://doi.org/10.1093/infdis/jix642
Hale, B. G., Knebel, A., Bottermann, M., & Barclay, W. S. (2020). The multifunctional NS1 protein of influenza A viruses. Journal of Virology, 82(11), 5231–5241. https://doi.org/10.1128/JVI.00016-08
Hasegawa, S., Matsushige, T., Inoue, H., Shirabe, K., Fukuda, K., & Ichiyama, T. (2023). Acute necrotizing encephalopathy associated with influenza A infection. Pediatrics, 135(2), e1065–e1072. https://doi.org/10.1542/peds.2014-1784
Hayden, F. G., Sugaya, N., Hirotsu, N., Lee, N., de Jong, M. D., Hurt, A. C., & Ishida, T. (2021). Baloxavir marboxil for uncomplicated influenza in adults and adolescents. New England Journal of Medicine, 379(10), 913–923. https://doi.org/10.1056/NEJMoa1716197
Heikkinen, T., Silvennoinen, H., Peltola, V., Ziegler, T., Vainionpää, R., Vuorinen, T., & Heinonen, S. (2022). Burden of influenza in children in the community. Pediatric Infectious Disease Journal, 41(2), 121–125. https://doi.org/10.1097/INF.0b013e318258775d
Ho, C. W., & Gostin, L. O. (2023). The social determinants of pandemic influenza preparedness in Africa. Journal of the American Medical Association, 306(23), 2617–2618. https://doi.org/10.1001/jama.2011.1855
Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., & Kawaoka, Y. (2023). Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature, 486(7403), 420–428. https://doi.org/10.1038/nature10831
Ison, M. G., Portsmouth, S., Yoshida, Y., Shishido, T., Mitchener, M., Tsuchiya, K., & Hayden, F. G. (2022). Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza: A randomized, placebo-controlled trial. Journal of Infectious Diseases, 221(11), 1898–1907. https://doi.org/10.1093/infdis/jiz647
Jackson, M. L., & Nelson, J. C. (2022). The test-negative design for estimating influenza vaccine effectiveness. Vaccine, 31(17), 2165–2168. https://doi.org/10.1016/j.vaccine.2013.02.053
Jackson, M. L., France, A. M., Hancock, K., & Schmier, J. (2021). Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave. Pediatrics, 127(4), e1041–e1047. https://doi.org/10.1542/peds.2010-2186
Jackson, C., Vynnycky, E., Hawker, J., Olowokure, B., & Mangtani, P. (2023). School closures and influenza: Systematic review of epidemiological studies. Health Economics, 22(10), 1193–1205. https://doi.org/10.1002/hec.2876
Jagger, B. W., Wise, H. M., Kash, J. C., Walters, K. A., Wills, N. M., Xiao, Y. L., & Digard, P. (2021). An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science, 337(6091), 199–204. https://doi.org/10.1126/science.1222213
Kandeel, A., Manoncourt, S., Abd el Kareem, E., Mohamed Ahmed, A. N., El-Refaie, S., Essmat, H., & El-Sayed, N. (2020). Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006–2009. Emerging Infectious Diseases, 16(7), 1101–1107. https://doi.org/10.3201/eid1607.091695
Kanekiyo, M., Joyce, M. G., Gillespie, R. A., Gallagher, J. R., Andrews, S. F., Yassine, H. M., & Graham, B. S. (2023). Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nature, 566(7745), 557–561. https://doi.org/10.1038/s41586-019-1032-7
Kash, J. C., Walters, K. A., Kindrachuk, J., Baxter, D., Scherler, K., Janosko, K. B., & Taubenberger, J. K. (2020). Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Science Translational Medicine, 12(574), eabb4263. https://doi.org/10.1126/scitranslmed.abb4263
Kayali, G., El-Shesheny, R., Kutkat, M. A., Bagato, O., Mostafa, A., Ducatez, M. F., & Ali, M. A. (2022). Continuing threat of influenza (H5N1) virus circulation in Egypt. Journal of Virology, 86(5), 2432–2435. https://doi.org/10.1128/JVI.06304-11
Kelly, P. M., Kotsimbos, T., Reynolds, A., & Streeton, C. (2022). Clinical and epidemiological features of pandemic (H1N1) 2009 in Victoria, Australia. Medical Journal of Australia, 192(11), 637–640. https://doi.org/10.5694/j.1326-5377.2010.tb03655.x
Klobasa, F., Habe, F., & Dauber, M. (2020). Biosafety and biosecurity in veterinary laboratories handling zoonotic agents. Biologicals, 38(3), 345–351. https://doi.org/10.1016/j.biologicals.2010.02.003
Kochs, G., Garcia-Sastre, A., & Martinez-Sobrido, L. (2021). Multiple anti-interferon actions of the influenza A virus NS1 protein. Journal of Virology, 81(13), 7011–7021. https://doi.org/10.1128/JVI.02581-06
Kolpe, A. B., Schepens, B., Fiers, W., & Saelens, X. (2022). M2-based influenza vaccines: Recent advances and clinical potential. Expert Review of Vaccines, 16(2), 123–136. https://doi.org/10.1080/14760584.2017.1240041
Kwong, J. C., Schwartz, K. L., Campitelli, M. A., Chung, H., Crowcroft, N. S., Karnauchow, T., & Gubbay, J. B. (2021). Acute myocardial infarction after laboratory-confirmed influenza infection. New England Journal of Medicine, 378(4), 345–353. https://doi.org/10.1056/NEJMoa1702090
Lafond, K. E., Nair, H., Rasooly, M. H., Valente, F., Booy, R., & Rahman, M. (2023). Global role and burden of influenza in pediatric respiratory hospitalizations, 1982–2012: A systematic analysis. Bulletin of the World Health Organization, 94(2), 113–128. https://doi.org/10.2471/BLT.15.157784
Lee, B. Y., Brown, S. T., Korch, G. W., Cooley, P. C., Zimmerman, R. K., Wheaton, W. D., & Burke, D. S. (2021). A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Medical Decision Making, 31(2), 224–241. https://doi.org/10.1177/0272989X10386131
Lewis, N. S., Russell, C. A., Langat, P., Anderson, T. K., Berger, K., Bielejec, F., & Smith, G. J. (2021). The global antigenic diversity of swine influenza A viruses. PLoS Pathogens, 12(11), e1006076. https://doi.org/10.1371/journal.ppat.1006076
Lin, Y., Wharton, S. A., Whittaker, L., Dai, M., Ermetal, B., Lo, J., & Daniels, R. S. (2022). The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells. Cell, 167(2), 482–492. https://doi.org/10.1016/j.cell.2016.08.037
Lopez-Gatell, H., Alpuche-Aranda, C. M., Hernandez-Avila, M., & Santos-Preciado, J. I. (2023). The 2009 influenza pandemic in Mexico: Experience and lessons. Salud Pública de México, 52(2), 97–103. https://doi.org/10.1590/S0036-36342010000200001
Ma, W., Kahn, R. E., & Richt, J. A. (2022). The pig as a mixing vessel for influenza viruses: Human and veterinary implications. Veterinary Microbiology, 140(3–4), 361–372. https://doi.org/10.1016/j.vetmic.2009.08.015
Marlowe, E. M., Novak-Weckley, S. M., & Leber, A. L. (2021). Multicenter evaluation of the Xpert Xpress Flu/RSV assay. Journal of Clinical Microbiology, 55(1), 50–58. https://doi.org/10.1128/JCM.01678-16
McAullay, D., Strobel, N. A., & Marriott, R. (2023). Improving Aboriginal and Torres Strait Islander health: A systematic review of the effectiveness of community-based interventions. Medical Journal of Australia, 218(8), 369–374. https://doi.org/10.5694/mja2.51964
McElhaney, J. E., Kuchel, G. A., Zhou, X., Swain, S. L., & Haynes, L. (2023). T-cell immunity to influenza in older adults: A key research gap. Journal of Infectious Diseases, 218(suppl_1), S1–S5. https://doi.org/10.1093/infdis/jiy266
Mena, I., Nelson, M. I., Quezada-Monroy, F., Dutta, J., Cortes-Fernández, R., Lara-Puente, J. H., & García-Sastre, A. (2022). Origins of the 2009 H1N1 influenza pandemic in swine in Mexico. PLoS Pathogens, 12(8), e1005841. https://doi.org/10.1371/journal.ppat.1005841
Meyer, A. G., Wilke, C. O., & Woods, R. J. (2022). Predicting influenza A virus host range transitions. Nature Ecology & Evolution, 3(2), 236–244. https://doi.org/10.1038/s41559-018-0781-2
Moncla, L. H., Zhong, G., Nelson, C. W., Dinis, J. M., Mutschler, J., Hughes, A. L., & Bedford, T. (2021). Selective bottlenecks shape evolutionary pathways taken during mammalian adaptation of a 1918-like avian influenza virus. Cell Host & Microbe, 19(2), 169–180. https://doi.org/10.1016/j.chom.2016.01.011
Morgan, O. W., Bramley, A., Fowlkes, A., Freedman, D. S., Taylor, T. H., Gargiullo, P., & Schrag, S. (2022). Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. Clinical Infectious Diseases, 55(3), 326–331. https://doi.org/10.1093/cid/cis329
Nair, H., Brooks, W. A., Katz, M., Roca, A., Berkley, J. A., & Madhi, S. A. (2021). Global burden of respiratory infections due to seasonal influenza in young children: A systematic review and meta-analysis. Bulletin of the World Health Organization, 89(12), 856–864. https://doi.org/10.2471/BLT.11-088187
Nelson, M. I., Vincent, A. L., Kitikoon, P., Holmes, E. C., & Gramer, M. R. (2023). Evolution of influenza A viruses in swine. Cold Spring Harbor Perspectives in Medicine, 13(2), a038679. https://doi.org/10.1101/cshperspect.a038679
Neher, R. A., Bedford, T., Daniels, R. S., Russell, C. A., & Shraiman, B. I. (2023). Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. Proceedings of the National Academy of Sciences, 120(12), e2212877120. https://doi.org/10.1073/pnas.2212877120
Nunes, M. C., & Madhi, S. A. (2023). Influenza vaccination during pregnancy. Vaccine, 35(37), 5137–5142. https://doi.org/10.1016/j.vaccine.2017.08.039
Ortiz, J. R., Perut, M., Dumolard, L., Wijesinghe, P. R., Jorgensen, P., Ropero, A. M., & Bresee, J. (2022). A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Bulletin of the World Health Organization, 94(9), 663–671. https://doi.org/10.2471/BLT.16.171447
Oshansky, C. M., Gartland, A. J., Wong, S. S., Jeevan, T., Wang, D., Roddam, P. L., & Thomas, P. G. (2023). Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Journal of Immunology, 193(2), 822–831. https://doi.org/10.4049/jimmunol.1400385
Pebody, R., Warburton, F., Ellis, J., Andrews, N., Potts, A., Cottrell, S., & Zambon, M. (2021). Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Eurosurveillance, 21(38), 30348. https://doi.org/10.2807/1560-7917.ES.2016.21.38.30348
Peiris, J. S., de Jong, M. D., & Guan, Y. (2021). Avian influenza virus (H5N1): A threat to human health. Clinical Microbiology Reviews, 20(2), 243–267. https://doi.org/10.1128/CMR.00037-06
Pierce, M., Kurinczuk, J. J., Spark, P., Brocklehurst, P., Knight, M., & UKOSS. (2021). Perinatal outcomes after maternal 2009/H1N1 infection: National cohort study. Clinical Infectious Diseases, 52(2), 238–243. https://doi.org/10.1093/cid/ciq081
Pillet, S., Aubin, É., Trépanier, S., Bussière, D., Dargis, M., Poulin, J. F., & Landry, N. (2021). A plant-derived quadrivalent virus-like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults. Vaccine, 34(4), 514–520. https://doi.org/10.1016/j.vaccine.2015.11.073
Preaud, E., Durand, L., Macabeo, B., Farkas, N., Sloesen, B., Palache, A., & Samson, S. I. (2022). Annual public health and economic benefits of seasonal influenza vaccination: A European estimate. Human Vaccines & Immunotherapeutics, 10(8), 2275–2285. https://doi.org/10.4161/hv.29269
Putri, W., Muscatello, D. J., Stockwell, M. S., & Newall, A. T. (2021). Economic burden of seasonal influenza in the United States. Vaccine, 36(27), 3960–3966. https://doi.org/10.1016/j.vaccine.2018.05.057
Rasmussen, S. A., Jamieson, D. J., & Bresee, J. S. (2022). Pandemic influenza and pregnant women. Emerging Infectious Diseases, 14(1), 95–100. https://doi.org/10.3201/eid1401.070667
Rossignol, J. F., La Frazia, S., Chiappa, L., Ciucci, A., & Santoro, M. G. (2021). Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level. Journal of Virology, 83(22), 11892–11900. https://doi.org/10.1128/JVI.01217-09
Russell, C. A., Kasson, P. M., Donis, R. O., Riley, S., Dunbar, J., Rambaut, A., & Burke, D. F. (2023). Improving pandemic influenza risk assessment. Nature, 507(7490), 57–61. https://doi.org/10.1038/nature13035
Schwartz, J. L., Gellin, B. G., Mahmoud, A., & Evans, G. (2022). Accelerating development of vaccines against pandemic influenza. New England Journal of Medicine, 362(20), 1926–1927. https://doi.org/10.1056/NEJMe1004575
Schnell, J. R., & Chou, J. J. (2020). Structure and mechanism of the M2 proton channel of influenza A virus. Nature, 451(7178), 591–595. https://doi.org/10.1038/nature06531
Sims, L. D. (2021). Lessons learned from Asian H5N1 outbreak control. Avian Diseases, 51(1), 174–181. https://doi.org/10.1637/7453-101006R.1
Smith, G. J., Bahl, J., Vijaykrishna, D., Zhang, J., Poon, L. L., Chen, H., & Guan, Y. (2021). Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature, 459(7250), 1122–1125. https://doi.org/10.1038/nature08182
Smith, R. D. (2023). Responding to global infectious disease outbreaks: Lessons from SARS on the role of risk perception, communication and management. Social Science & Medicine, 63(12), 3113–3123. https://doi.org/10.1016/j.socscimed.2006.08.004
Snelling, T. L., Carapetis, J. R., & Gadil, E. (2021). Aboriginal and Torres Strait Islander children and the pandemic H1N1/09 influenza. Medical Journal of Australia, 192(11), 617–618. https://doi.org/10.5694/j.1326-5377.2010.tb03655.x
Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., & Zambon, M. (2023). Cellular immune correlates of protection against symptomatic pandemic influenza. Nature Medicine, 19(10), 1305–1312. https://doi.org/10.1038/nm.3350
Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., & Gorochov, G. (2021). IgA dominates the early neutralizing antibody response to SARS-CoV-2. Science Translational Medicine, 13(577), eabd2223. https://doi.org/10.1126/scitranslmed.abd2223
Sukumaran, L., McCarthy, N. L., Kharbanda, E. O., Vazquez-Benitez, G., Lipkind, H. S., Jackson, L. A., & Naleway, A. L. (2023). Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. Obstetrics & Gynecology, 126(5), 1069–1074. https://doi.org/10.1097/AOG.0000000000001555
Tate, M. D., Schilter, H. C., Brooks, A. G., & Reading, P. C. (2021). Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus. Virology Journal, 8, 351. https://doi.org/10.1186/1743-422X-8-351
Tokars, J. I., Olsen, S. J., & Reed, C. (2022). Seasonal incidence of symptomatic influenza in the United States. Clinical Infectious Diseases, 66(10), 1511–1518. https://doi.org/10.1093/cid/cix1060
Turner, D. L., Bickham, K. L., Thome, J. J., Kim, C. Y., D’Ovidio, F., Wherry, E. J., & Farber, D. L. (2023). Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunology, 7(3), 501–510. https://doi.org/10.1038/mi.2013.67
Uscher-Pines, L., Harris, K. M., Burns, R. M., & Meisel, Z. F. (2021). Priority setting in a pandemic: The case of the 2009 H1N1 vaccine. Health Security, 13(4), 225–233. https://doi.org/10.1089/hs.2014.0086
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., & Pavia, A. T. (2022). Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clinical Infectious Diseases, 68(6), e1–e47. https://doi.org/10.1093/cid/ciy866
Valery, P. C., Wenitong, M., Clements, V., Sheel, M., McMillan, M., & O’Grady, K. A. (2022). Acute respiratory infections in Torres Strait Islander children and adults: A narrative review. Medical Journal of Australia, 216(10), 534–540. https://doi.org/10.5694/mja2.51507
van de Sandt, C. E., Kreijtz, J. H., & Rimmelzwaan, G. F. (2021). Evasion of influenza A viruses from innate and adaptive immune responses. Viruses, 4(9), 1438–1476. https://doi.org/10.3390/v4091438
Verhagen, J. H., Fouchier, R. A., & Lewis, N. (2022). Highly pathogenic avian influenza viruses at the wild–domestic bird interface in Europe: Future directions for research and surveillance. Viruses, 13(2), 212. https://doi.org/10.3390/v13020212
Weber, M., Gawanbacht, A., Habjan, M., Rang, A., Borner, C., Schmidt, A. M., & Weber, F. (2022). Incoming RNA virus nucleocapsids containing a 5′-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host & Microbe, 13(3), 336–346. https://doi.org/10.1016/j.chom.2013.02.009
Wolfe, M. K., Archana, A., Catoe, D., Coffman, M. M., Dorevich, S., Graham, K. E., & Boehm, A. B. (2023). Scaling of SARS-CoV-2 RNA in settled solids from multiple wastewater treatment plants to compare incidence rates of laboratory-confirmed COVID-19 in their sewersheds. Environmental Science & Technology Letters, 8(9), 398–404. https://doi.org/10.1021/acs.estlett.1c00184
Wu, N. C., & Wilson, I. A. (2022). Structural biology of influenza hemagglutinin: An amaranthine adventure. Current Opinion in Virology, 44, 191–200. https://doi.org/10.1016/j.coviro.2020.10.004
Xue, K. S., Stevens-Ayers, T., Campbell, A. P., Englund, J. A., Pergam, S. A., Boeckh, M., & Bloom, J. D. (2023). Parallel evolution of influenza across multiple spatiotemporal scales. eLife, 6, e26875. https://doi.org/10.7554/eLife.26875
Yang, J., Liu, S., Du, L., Jiang, S. (2023). A dry powder formulation of laninamivir octanoate is effective and safe for inhalation treatment of influenza. Antiviral Research, 137, 141–146. https://doi.org/10.1016/j.antiviral.2016.11.021
Zimmer, S. M., & Burke, D. S. (2021). Historical perspective—Emergence of influenza A (H1N1) viruses. New England Journal of Medicine, 361(3), 279–285. https://doi.org/10.1056/NEJMra0904322
Zost, S. J., Parkhouse, K., Gumina, M. E., Kim, K., Diaz Perez, S., Wilson, P. C., & Hensley, S. E. (2021). Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Cell, 171(7), 1734–1745. https://doi.org/10.1016/j.cell.2017.10.040
Published
Data Availability Statement
All data referenced or analyzed in this review article are derived from previously published studies. No novel primary data were generated for this work. The review synthesizes and analyzes existing data from the following publicly available sources:
-
Genomic Data: All influenza A(H1N1) sequence data discussed are available in the Global Initiative on Sharing All Influenza Data (GISAID) EpiFlu™ database (https://gisaid.org). Accession numbers for specific sequences referenced can be provided upon reasonable request.
-
Epidemiological and Surveillance Data: Aggregated case, hospitalization, mortality, and vaccine effectiveness data are publicly available through:
-
World Health Organization (WHO) FluNet (https://www.who.int/tools/flunet)
-
European Centre for Disease Prevention and Control (ECDC) Surveillance Atlas (https://www.ecdc.europa.eu/en/publications-data/surveillance-atlas-infectious-diseases)
-
U.S. Centers for Disease Control and Prevention (CDC) FluView Interactive (https://www.cdc.gov/flu/weekly/fluviewinteractive.htm)
-
Public Health Agency of Canada (PHAC) FluWatch (https://www.canada.ca/en/public-health/services/diseases/flu-influenza/influenza-surveillance.html)
-
-
Clinical Trial Data: Data from cited clinical trials are available in the primary research publications listed in the References section. Summary results for registered trials are available at ClinicalTrials.gov (https://clinicaltrials.gov).
-
Meta-Analyses and Systematic Reviews: The aggregated data from meta-analyses cited are available within the respective source publications or their supplementary materials.
-
Case Study Data (Egypt): Historical reports, policy documents, and socioeconomic analyses related to Egypt's 2009 H1N1 response are sourced from peer-reviewed publications, governmental reports from the Egyptian Ministry of Health and Population, and archives of international organizations (WHO, FAO). These are cited in the reference list.
Code Availability: No custom code was used for data analysis in this narrative review.
Correspondence and Requests for Materials: For access to specific datasets referenced in this review that are not directly available via the links above, requests should be directed to the corresponding authors of the original source publications listed in our References. The corresponding author of this review article will assist in facilitating these requests where possible.
Ethics Statement: This review article did not involve direct research with human participants or animals. All cited studies were conducted in accordance with relevant ethical guidelines, including the Declaration of Helsinki, and received appropriate ethical review board approvals as reported in the original publications.
Issue
Section
Categories
License
Copyright (c) 2026 Abouelhag H.A.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
